The Case for Abandoning Induction Chemotherapy
Dr. Pollyea discusses reconsidering the treatment of acute myeloid leukemia solely with intensive induction chemotherapy.
Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease
Dr. DeBaun looks at experiments using ARQ 092 as a possible therapeutic agent for preventing acute vaso-occlusive events in sickle cell disease.
Download issue as PDF
Dr. Adesina discusses the important role mentors have played in her growth and development as a medical professional specializing in SCD.
Dr. Coetzer discusses a study that provides insights into the potential of new drugs to treat CML.
Dr. Hoggatt looks at the therapeutic effects of blocking CD47 aside from alerting macrophages to devour tumor cells.
Dr. Garcia reviews a study that shows the importance of an accurate 4Ts assessment.
Dr. LaCasce discusses a new prognostic model in follicular lymphoma that incorporates both genetic and clinical factors.
Drs. Raje and Yee discuss two trials with elotuzumab and daratumumab that use monoclonal antibodies in the treatment of multiple myeloma.
Dr. Koury studies increase in platelet production and size due to the IL-1α-induced megakaryocyte rupture mechanism of rapid platelet production.
Dr. Raetz looks at a study that highlights the importance of the purine synthesis pathway in relapsed ALL.
Dr. Cuker studies the use of idarucizumab, a monoclonal antibody fragment, to reverse the anticoagulant effect of dabigatran in bleeding patients.
Drs. Oh and Fisher discuss the application of mass cytometry to analyze disease evolution in hematologic malignancies.
Dr. Quinn discusses the REACH study as part of several studies that look at hydroxyurea for the treatment of children with sickle cell anemia in sub-Saharan Africa.
Drs. Valent, Schumacher, Sörgel, Horny, and Groner talk about Paul Ehrlich's many achievements on the 100th anniversary of his death.
Dr. Williams talks about ASH's influence in the development of precision medicine, which is a big part of the new ASH Research Agenda.
May-June 2017Volume 14, Issue 3
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology